US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Altimmune, Inc.

3.08

-0.0350-1.13%

Volume:879.13K

Turnover:2.71M

Market Cap:596.55M

PE:-4.05

High:3.11

Open:3.08

Low:3.06

Close:3.11

52wk High:6.44

52wk Low:2.56

Shares:194.00M

Float Shares:164.00M

Volume Ratio:0.36

T/O Rate:0.54%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7600

EPS(LYR):-0.9999

ROE:-28.87%

ROA:-17.20%

PB:1.26

PE(LYR):-3.08

Loading ...

Overview Company News Filings

U.S. Stocks on the MOVE-Visa, CMS Energy, Ecolab

Barclays says trial data highlights meaningful opportunity for Altimmune in AUD

H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune

Leerink remains bullish on Altimmune following ‘positive’ AUD trial results

Unusually active option classes on open July 28th

Altimmune's Investigational Alcohol Use Disorder Drug Meets Primary Endpoint in Phase 2 Study

MT Newswires Live

Altimmune Shares Jump Premarket After Positive Results in Phase 2 Trial of Pemvidutide

Altimmune Jumps as Experimental Obesity Drug Shows Benefit in Alcohol Use Disorder Study

Altimmune Shares up 17% Premarket as Co's Drug Meets Main Goal of Mid-Stage Study for Alcohol Use Disorder

THOMSON REUTERS

Altimmune's Drug Meets Main Goal of Mid-stage Study for Alcohol Use Disorder

Altimmune - to Request End-of-Phase 2 Meeting with FDA for Pemvidutide in AUD

THOMSON REUTERS

Altimmune - Pemvidutide Meets FDA-Recognized Registrational Endpoints in Phase 2 Trial

THOMSON REUTERS

Altimmune Announces Positive Topline Results from Reclaim Phase 2 Trial of Pemvidutide in Alcohol Use Disorder

THOMSON REUTERS

Altimmune - Pemvidutide 2.4 Mg Achieves Significant Reduction in Heavy Drinking Days in Phase 2 Trial

THOMSON REUTERS

Altimmune - Pemvidutide Demonstrates Generally Favorable Tolerability Profile in Phase 2 Trial

THOMSON REUTERS

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

Unusually active option classes on open June 24th

Altimmune Initiated at Outperform by Leerink Partners

Leerink Partners Initiates Altimmune at Outperform With $10 Price Target

MT Newswires Live

Altimmune Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $10

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ALT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":3.075,"timestamp":1788200955282,"preClose":3.11,"halted":0,"volume":879131,"delay":0,"changeRate":-0.011254019292604405,"floatShares":164000000,"shares":194000000,"eps":-0.76,"marketStatus":"Trading","change":-0.035,"latestTime":"08-31 14:29:21 EDT","open":3.08,"high":3.11,"low":3.06,"amount":2713700.4279297,"amplitude":0.016077,"askPrice":3.08,"askSize":2055,"bidPrice":3.07,"bidSize":3230,"shortable":3,"etf":0,"ttmEps":-0.76,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.11,"preHourTrading":{"tag":"盘前","latestPrice":3.1,"preClose":3.11,"latestTime":"09:27 EDT","volume":13506,"amount":41936.0273544,"timestamp":1788182858036,"change":-0.01,"changeRate":-0.003215,"amplitude":0.012894},"postHourTrading":{"tag":"盘后","latestPrice":3.1214,"preClose":3.11,"latestTime":"19:59 EDT","volume":13058,"amount":40699.1676,"timestamp":1787961541806,"change":0.0114,"changeRate":0.003666,"amplitude":0.009646},"volumeRatio":0.355655,"impliedVol":0.8588,"impliedVolPercentile":0.4143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALT\",,,,,undefined,":{"symbol":"ALT","floatShares":164000000,"roa":"-17.20%","roe":"-28.87%","lyrEps":-0.999873,"volumeRatio":0.355655,"shares":194000000,"dividePrice":0,"high":3.11,"amplitude":0.016077,"preClose":3.11,"low":3.06,"week52Low":2.56,"pbRate":"1.26","psRate":"19243.55","week52High":6.4399,"institutionHeld":0.7624,"latestPrice":3.075,"committee":0.222327,"eps":-0.76,"divideRate":0,"volume":879131,"delay":0,"ttmEps":-0.76,"open":3.08,"prevYearClose":3.61,"prevWeekClose":3.11,"prevMonthClose":2.84,"prevQuarterClose":3.04,"fiveDayClose":3.11,"twentyDayClose":3,"sixtyDayClose":2.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"ALT","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.12},{"market":"US","date":"2026-05-13","symbol":"ALT","fiscalQuarterEnding":"2026/03","expectedEps":-0.25,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2026-03-05","symbol":"ALT","fiscalQuarterEnding":"2025/12","expectedEps":-0.25,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":-0.27},{"market":"US","date":"2025-11-06","symbol":"ALT","fiscalQuarterEnding":"2025/09","expectedEps":-0.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2025-08-12","symbol":"ALT","fiscalQuarterEnding":"2025/06","expectedEps":-0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.6364,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6364,"analysts":11,"updateTime":1782187200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALT","date":"2026-08-28","current":-4.046053,"percent":0.123779,"low":-11.212671,"twenty":-6.456483,"median":-4.961303,"eighty":-3.279387,"high":-1.406077,"avg":-4.944975,"sd":1.9228,"marketCap":630237351},"quantilePoints":[{"date":"2021-09-03","current":-9.554361,"twenty":-9.558349,"median":-1.132786,"eighty":-0.630952,"marketCap":650488690},{"date":"2021-09-10","current":-9.775338,"twenty":-9.591169,"median":-1.136512,"eighty":-0.630952,"marketCap":665533468},{"date":"2021-09-17","current":-8.862353,"twenty":-9.605176,"median":-1.137989,"eighty":-0.631686,"marketCap":603374780},{"date":"2021-09-24","current":-8.705343,"twenty":-9.600447,"median":-1.155144,"eighty":-0.635355,"marketCap":592685069},{"date":"2021-10-01","current":-6.949155,"twenty":-9.591169,"median":-1.16462,"eighty":-0.638289,"marketCap":473118675},{"date":"2021-10-08","current":-7.077089,"twenty":-9.559679,"median":-1.173775,"eighty":-0.638289,"marketCap":481828810},{"date":"2021-10-15","current":-6.984046,"twenty":-9.554182,"median":-1.181272,"eighty":-0.638815,"marketCap":475494167},{"date":"2021-10-22","current":-6.699101,"twenty":-9.550655,"median":-1.192207,"eighty":-0.641115,"marketCap":456094321},{"date":"2021-10-29","current":-6.280407,"twenty":-9.538907,"median":-1.192406,"eighty":-0.641912,"marketCap":427588426},{"date":"2021-11-05","current":-6.303668,"twenty":-9.536915,"median":-1.195875,"eighty":-0.642691,"marketCap":429172087},{"date":"2021-11-12","current":-5.254536,"twenty":-9.534318,"median":-1.207066,"eighty":-0.645626,"marketCap":440449772},{"date":"2021-11-19","current":-4.989681,"twenty":-9.517742,"median":-1.21849,"eighty":-0.645626,"marketCap":418248884},{"date":"2021-11-26","current":-4.928196,"twenty":-9.492985,"median":-1.222217,"eighty":-0.645626,"marketCap":413095106},{"date":"2021-12-03","current":-4.483618,"twenty":-9.492985,"median":-1.234811,"eighty":-0.645626,"marketCap":375829329},{"date":"2021-12-10","current":-4.455241,"twenty":-9.478066,"median":-1.237122,"eighty":-0.645626,"marketCap":373450662},{"date":"2021-12-17","current":-4.426864,"twenty":-9.474354,"median":-1.242711,"eighty":-0.645626,"marketCap":371071995},{"date":"2021-12-23","current":-4.351191,"twenty":-9.464501,"median":-1.250163,"eighty":-0.64856,"marketCap":364728884},{"date":"2021-12-31","current":-4.332272,"twenty":-9.444757,"median":-1.266932,"eighty":-0.649294,"marketCap":363143107},{"date":"2022-01-07","current":-3.916072,"twenty":-9.429228,"median":-1.270658,"eighty":-0.649294,"marketCap":328255996},{"date":"2022-01-14","current":-3.707971,"twenty":-9.419545,"median":-1.300468,"eighty":-0.649294,"marketCap":310812440},{"date":"2022-01-21","current":-3.305959,"twenty":-9.395156,"median":-1.357281,"eighty":-0.649294,"marketCap":277114663},{"date":"2022-01-28","current":-3.40528,"twenty":-9.375518,"median":-1.896273,"eighty":-0.649294,"marketCap":285439996},{"date":"2022-02-04","current":-3.622839,"twenty":-9.356009,"median":-2.181903,"eighty":-0.649294,"marketCap":303676441},{"date":"2022-02-11","current":-3.632298,"twenty":-9.294535,"median":-2.226131,"eighty":-0.651495,"marketCap":304469329},{"date":"2022-02-18","current":-3.339066,"twenty":-9.255468,"median":-2.240874,"eighty":-0.652962,"marketCap":279889774},{"date":"2022-02-25","current":-3.599191,"twenty":-9.25041,"median":-2.262988,"eighty":-0.65443,"marketCap":301694218},{"date":"2022-03-04","current":-3.277582,"twenty":-9.216158,"median":-2.281416,"eighty":-0.656631,"marketCap":274735996},{"date":"2022-03-11","current":-3.29177,"twenty":-9.164959,"median":-2.299844,"eighty":-0.656631,"marketCap":275925330},{"date":"2022-03-18","current":-3.187041,"twenty":-9.152685,"median":-2.321958,"eighty":-0.656631,"marketCap":309429796},{"date":"2022-03-25","current":-2.824576,"twenty":-9.120812,"median":-2.329329,"eighty":-0.656889,"marketCap":274238058},{"date":"2022-04-01","current":-2.749431,"twenty":-9.069815,"median":-2.351443,"eighty":-0.658485,"marketCap":266942209},{"date":"2022-04-08","current":-2.510734,"twenty":-9.026468,"median":-2.395671,"eighty":-0.660299,"marketCap":243767162},{"date":"2022-04-14","current":-2.31182,"twenty":-9.002244,"median":-2.403042,"eighty":-0.660299,"marketCap":224454623},{"date":"2022-04-22","current":-2.006819,"twenty":-8.981208,"median":-2.373557,"eighty":-0.660299,"marketCap":194842063},{"date":"2022-04-29","current":-1.997978,"twenty":-8.97802,"median":-2.3367,"eighty":-0.660463,"marketCap":193983728},{"date":"2022-05-06","current":-1.913993,"twenty":-8.974196,"median":-2.325643,"eighty":-0.661689,"marketCap":185829544},{"date":"2022-05-13","current":-2.19104,"twenty":-8.962867,"median":-2.314587,"eighty":-0.663967,"marketCap":222734186},{"date":"2022-05-20","current":-2.131593,"twenty":-8.93653,"median":-2.296159,"eighty":-0.664701,"marketCap":216691010},{"date":"2022-05-27","current":-2.13584,"twenty":-8.925681,"median":-2.280878,"eighty":-0.66787,"marketCap":217122666},{"date":"2022-06-03","current":-2.309934,"twenty":-8.905008,"median":-2.27773,"eighty":-0.668807,"marketCap":234820537},{"date":"2022-06-10","current":-3.630503,"twenty":-8.886226,"median":-2.28299,"eighty":-0.668883,"marketCap":369065367},{"date":"2022-06-17","current":-3.830074,"twenty":-8.882388,"median":-2.299844,"eighty":-0.671304,"marketCap":389353170},{"date":"2022-06-24","current":-4.369342,"twenty":-8.86636,"median":-2.31182,"eighty":-0.671304,"marketCap":444173406},{"date":"2022-07-01","current":-4.781223,"twenty":-8.859328,"median":-2.321958,"eighty":-0.671304,"marketCap":486043980},{"date":"2022-07-08","current":-5.379938,"twenty":-8.843395,"median":-2.329329,"eighty":-0.672112,"marketCap":546907391},{"date":"2022-07-15","current":-4.810947,"twenty":-8.833277,"median":-2.3367,"eighty":-0.673733,"marketCap":489065568},{"date":"2022-07-22","current":-5.554032,"twenty":-8.79056,"median":-2.3883,"eighty":-0.674765,"marketCap":564605263},{"date":"2022-07-29","current":-5.099688,"twenty":-8.752462,"median":-2.431168,"eighty":-0.674972,"marketCap":518418135},{"date":"2022-08-05","current":-5.26529,"twenty":-8.743932,"median":-2.458327,"eighty":-0.677129,"marketCap":535252696},{"date":"2022-08-12","current":-8.685942,"twenty":-8.727192,"median":-2.479782,"eighty":-0.678611,"marketCap":841987671},{"date":"2022-08-19","current":-8.585874,"twenty":-8.767651,"median":-2.479782,"eighty":-0.678611,"marketCap":832287353},{"date":"2022-08-26","current":-9.231316,"twenty":-8.857064,"median":-2.479782,"eighty":-0.678611,"marketCap":894854409},{"date":"2022-09-02","current":-11.212671,"twenty":-8.915344,"median":-2.479782,"eighty":-0.678611,"marketCap":1086920721},{"date":"2022-09-09","current":-9.996839,"twenty":-8.976745,"median":-2.479782,"eighty":-0.678611,"marketCap":969061848},{"date":"2022-09-16","current":-6.839679,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":663016789},{"date":"2022-09-23","current":-6.189234,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":599964717},{"date":"2022-09-30","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-10-07","current":-5.28636,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":512442952},{"date":"2022-10-14","current":-5.256037,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":509503508},{"date":"2022-10-21","current":-5.422815,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525670447},{"date":"2022-10-28","current":-6.453807,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":625611519},{"date":"2022-11-04","current":-5.983796,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":580050148},{"date":"2022-11-11","current":-6.042666,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":525366485},{"date":"2022-11-18","current":-4.996929,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":434447121},{"date":"2022-11-25","current":-5.138245,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":446733522},{"date":"2022-12-02","current":-6.376172,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":554362390},{"date":"2022-12-09","current":-5.709161,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":496370580},{"date":"2022-12-16","current":-6.489225,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":564191510},{"date":"2022-12-23","current":-8.665489,"twenty":-8.992045,"median":-2.479782,"eighty":-0.678611,"marketCap":753402078},{"date":"2022-12-30","current":-9.298584,"twenty":-9.046009,"median":-2.479782,"eighty":-0.678611,"marketCap":808445152},{"date":"2023-01-06","current":-8.077615,"twenty":-9.046009,"median":-2.550468,"eighty":-0.678611,"marketCap":702290652},{"date":"2023-01-13","current":-9.208142,"twenty":-9.082964,"median":-2.674285,"eighty":-0.678611,"marketCap":800581856},{"date":"2023-01-20","current":-8.111531,"twenty":-9.082964,"median":-2.74501,"eighty":-0.678611,"marketCap":705239388},{"date":"2023-01-27","current":-7.478436,"twenty":-9.082964,"median":-2.834635,"eighty":-0.678611,"marketCap":650196314},{"date":"2023-02-03","current":-8.569394,"twenty":-9.082964,"median":-3.041104,"eighty":-0.682837,"marketCap":745047326},{"date":"2023-02-10","current":-7.591488,"twenty":-9.082964,"median":-3.089794,"eighty":-0.692599,"marketCap":660025434},{"date":"2023-02-17","current":-6.760551,"twenty":-9.082964,"median":-3.29177,"eighty":-0.706713,"marketCap":587781399},{"date":"2023-02-24","current":-6.771856,"twenty":-9.082964,"median":-3.329607,"eighty":-0.719867,"marketCap":588764311},{"date":"2023-03-03","current":-6.742082,"twenty":-9.082964,"median":-3.358746,"eighty":-0.742102,"marketCap":571141998},{"date":"2023-03-10","current":-6.032389,"twenty":-9.082964,"median":-3.414739,"eighty":-0.768114,"marketCap":511021788},{"date":"2023-03-17","current":-6.404687,"twenty":-9.082964,"median":-3.495141,"eighty":-0.78253,"marketCap":542560259},{"date":"2023-03-24","current":-2.513011,"twenty":-9.082964,"median":-3.5046,"eighty":-0.796016,"marketCap":212884679},{"date":"2023-03-31","current":-2.454839,"twenty":-9.080548,"median":-3.499871,"eighty":-0.802556,"marketCap":207956793},{"date":"2023-04-06","current":-2.251239,"twenty":-9.080548,"median":-3.499871,"eighty":-0.804482,"marketCap":190709192},{"date":"2023-04-14","current":-2.681708,"twenty":-9.082964,"median":-3.5046,"eighty":-0.809804,"marketCap":227175549},{"date":"2023-04-21","current":-3.33323,"twenty":-9.082964,"median":-3.5046,"eighty":-0.816048,"marketCap":282367873},{"date":"2023-04-28","current":-2.885309,"twenty":-9.085381,"median":-3.51872,"eighty":-0.82152,"marketCap":244423150},{"date":"2023-05-05","current":-2.873674,"twenty":-9.085381,"median":-3.51872,"eighty":-0.831857,"marketCap":243437573},{"date":"2023-05-12","current":-3.100543,"twenty":-9.085381,"median":-3.51872,"eighty":-0.840814,"marketCap":262656329},{"date":"2023-05-19","current":-2.569103,"twenty":-9.085381,"median":-3.51872,"eighty":-0.844264,"marketCap":219290931},{"date":"2023-05-26","current":-2.431202,"twenty":-9.085381,"median":-3.51872,"eighty":-0.854355,"marketCap":207520115},{"date":"2023-06-02","current":-2.396553,"twenty":-9.085381,"median":-3.51872,"eighty":-0.858045,"marketCap":204562584},{"date":"2023-06-09","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.86619,"marketCap":201605053},{"date":"2023-06-16","current":-2.361904,"twenty":-9.085381,"median":-3.51872,"eighty":-0.879261,"marketCap":201605053},{"date":"2023-06-23","current":-2.402328,"twenty":-9.087797,"median":-3.53284,"eighty":-0.88307,"marketCap":205055506},{"date":"2023-06-30","current":-2.021189,"twenty":-9.090214,"median":-3.532909,"eighty":-0.895974,"marketCap":172522661},{"date":"2023-07-07","current":-1.940342,"twenty":-9.090214,"median":-3.532909,"eighty":-0.899395,"marketCap":165621755},{"date":"2023-07-14","current":-1.957666,"twenty":-9.090214,"median":-3.532909,"eighty":-0.906287,"marketCap":167100520},{"date":"2023-07-21","current":-1.836395,"twenty":-9.090214,"median":-3.532909,"eighty":-0.909901,"marketCap":156749161},{"date":"2023-07-28","current":-1.726673,"twenty":-9.090214,"median":-3.532909,"eighty":-0.919185,"marketCap":147383645},{"date":"2023-08-04","current":-1.795971,"twenty":-9.090214,"median":-3.532909,"eighty":-0.928329,"marketCap":153298707},{"date":"2023-08-11","current":-1.969804,"twenty":-9.090214,"median":-3.532909,"eighty":-0.937755,"marketCap":160166735},{"date":"2023-08-18","current":-1.743017,"twenty":-9.090214,"median":-3.532909,"eighty":-0.941735,"marketCap":141726485},{"date":"2023-08-25","current":-1.587507,"twenty":-9.090214,"median":-3.532909,"eighty":-0.945086,"marketCap":129081743},{"date":"2023-09-01","current":-1.639343,"twenty":-9.090214,"median":-3.532909,"eighty":-0.956324,"marketCap":133296657},{"date":"2023-09-08","current":-1.593986,"twenty":-9.090214,"median":-3.532909,"eighty":-0.958492,"marketCap":129608607},{"date":"2023-09-15","current":-1.807814,"twenty":-9.090214,"median":-3.532909,"eighty":-0.970251,"marketCap":146995128},{"date":"2023-09-22","current":-1.658782,"twenty":-9.090214,"median":-3.532909,"eighty":-0.979536,"marketCap":134877250},{"date":"2023-09-29","current":-1.619905,"twenty":-9.090214,"median":-3.532909,"eighty":-0.985303,"marketCap":131716065},{"date":"2023-10-06","current":-1.684701,"twenty":-9.090214,"median":-3.532909,"eighty":-0.991188,"marketCap":136984707},{"date":"2023-10-13","current":-1.69118,"twenty":-9.090214,"median":-3.532909,"eighty":-1.00206,"marketCap":137511571},{"date":"2023-10-20","current":-1.509751,"twenty":-9.090214,"median":-3.532909,"eighty":-1.006093,"marketCap":122759372},{"date":"2023-10-27","current":-1.503271,"twenty":-9.120812,"median":-3.537707,"eighty":-1.019689,"marketCap":122232508},{"date":"2023-11-03","current":-1.658782,"twenty":-9.120812,"median":-3.537707,"eighty":-1.028451,"marketCap":134877250},{"date":"2023-11-10","current":-1.677615,"twenty":-9.120812,"median":-3.537707,"eighty":-1.034911,"marketCap":131635733},{"date":"2023-11-17","current":-1.615988,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":126800135},{"date":"2023-11-24","current":-1.924122,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":150978127},{"date":"2023-12-01","current":-2.163781,"twenty":-9.120812,"median":-3.537707,"eighty":-1.035705,"marketCap":169783232},{"date":"2023-12-08","current":-4.505594,"twenty":-9.110613,"median":-3.544802,"eighty":-1.035771,"marketCap":353535971},{"date":"2023-12-15","current":-4.793186,"twenty":-9.110613,"median":-3.60865,"eighty":-1.041865,"marketCap":376102097},{"date":"2023-12-22","current":-5.402605,"twenty":-9.110613,"median":-3.686688,"eighty":-1.046438,"marketCap":423920792},{"date":"2023-12-29","current":-7.956688,"twenty":-9.120812,"median":-3.745808,"eighty":-1.059015,"marketCap":624329481},{"date":"2024-01-05","current":-8.00462,"twenty":-9.131012,"median":-3.795468,"eighty":-1.062066,"marketCap":628090501},{"date":"2024-01-12","current":-7.867672,"twenty":-9.131012,"median":-3.884844,"eighty":-1.073911,"marketCap":617344727},{"date":"2024-01-19","current":-7.388353,"twenty":-9.141211,"median":-4.008415,"eighty":-1.078488,"marketCap":579734518},{"date":"2024-01-26","current":-6.354395,"twenty":-9.131012,"median":-4.119442,"eighty":-1.078619,"marketCap":498603922},{"date":"2024-02-02","current":-6.765239,"twenty":-9.131012,"median":-4.20221,"eighty":-1.078619,"marketCap":530841245},{"date":"2024-02-09","current":-6.635138,"twenty":-9.131012,"median":-4.339366,"eighty":-1.078619,"marketCap":520632759},{"date":"2024-02-16","current":-6.12843,"twenty":-9.131012,"median":-4.37682,"eighty":-1.078619,"marketCap":480873395},{"date":"2024-02-23","current":-6.073651,"twenty":-9.131012,"median":-4.459875,"eighty":-1.082595,"marketCap":476575085},{"date":"2024-03-01","current":-8.285364,"twenty":-9.152685,"median":-4.505594,"eighty":-1.101931,"marketCap":650119339},{"date":"2024-03-08","current":-6.86795,"twenty":-9.152685,"median":-4.658612,"eighty":-1.122353,"marketCap":538900576},{"date":"2024-03-15","current":-6.864526,"twenty":-9.152685,"median":-4.78631,"eighty":-1.163594,"marketCap":538631931},{"date":"2024-03-22","current":-6.237989,"twenty":-9.152685,"median":-4.819439,"eighty":-1.201744,"marketCap":489470014},{"date":"2024-03-28","current":-7.125839,"twenty":-9.152685,"median":-4.887378,"eighty":-1.371955,"marketCap":630259092},{"date":"2024-04-05","current":-7.133855,"twenty":-9.15651,"median":-4.944847,"eighty":-1.549925,"marketCap":630968045},{"date":"2024-04-12","current":-6.733076,"twenty":-9.15651,"median":-4.976853,"eighty":-1.582323,"marketCap":595520402},{"date":"2024-04-19","current":-5.522726,"twenty":-9.15651,"median":-5.010669,"eighty":-1.603058,"marketCap":488468520},{"date":"2024-04-26","current":-5.771208,"twenty":-9.152685,"median":-5.065719,"eighty":-1.622497,"marketCap":510446059},{"date":"2024-05-03","current":-5.763193,"twenty":-9.152685,"median":-5.137904,"eighty":-1.632864,"marketCap":509737106},{"date":"2024-05-10","current":-5.900173,"twenty":-9.152685,"median":-5.17612,"eighty":-1.651056,"marketCap":547341314},{"date":"2024-05-17","current":-6.802306,"twenty":-9.152685,"median":-5.23434,"eighty":-1.663576,"marketCap":631029499},{"date":"2024-05-24","current":-5.648207,"twenty":-9.152685,"median":-5.250196,"eighty":-1.680449,"marketCap":523967191},{"date":"2024-05-31","current":-5.365414,"twenty":-9.152685,"median":-5.252552,"eighty":-1.69118,"marketCap":497733380},{"date":"2024-06-07","current":-5.143766,"twenty":-9.152685,"median":-5.262603,"eighty":-1.719691,"marketCap":477171745},{"date":"2024-06-14","current":-5.05205,"twenty":-9.15651,"median":-5.263947,"eighty":-1.733603,"marketCap":468663482},{"date":"2024-06-21","current":-4.539966,"twenty":-9.160335,"median":-5.26529,"eighty":-1.749497,"marketCap":421159014},{"date":"2024-06-28","current":-4.880081,"twenty":-9.164959,"median":-5.282272,"eighty":-1.761776,"marketCap":452710489},{"date":"2024-07-05","current":-5.044407,"twenty":-9.164959,"median":-5.287002,"eighty":-1.782905,"marketCap":467954460},{"date":"2024-07-12","current":-5.869855,"twenty":-9.164959,"median":-5.307752,"eighty":-1.813296,"marketCap":544528826},{"date":"2024-07-15","current":-6.038002,"twenty":-9.164959,"median":-5.325968,"eighty":-1.814927,"marketCap":560127308},{"date":"2024-08-02","current":-4.654611,"twenty":-9.22331,"median":-5.382384,"eighty":-1.858355,"marketCap":431794343},{"date":"2024-08-09","current":-4.4375,"twenty":-9.22331,"median":-5.382384,"eighty":-1.898763,"marketCap":449722870},{"date":"2024-08-16","current":-4.375927,"twenty":-9.22331,"median":-5.382384,"eighty":-1.922746,"marketCap":443482734},{"date":"2024-08-23","current":-4.740588,"twenty":-9.22331,"median":-5.382384,"eighty":-1.94836,"marketCap":480439628},{"date":"2024-08-30","current":-4.635397,"twenty":-9.22331,"median":-5.382384,"eighty":-1.963276,"marketCap":469778986},{"date":"2024-09-06","current":-4.481118,"twenty":-9.22331,"median":-5.382384,"eighty":-1.992315,"marketCap":454143376},{"date":"2024-09-13","current":-4.97902,"twenty":-9.22331,"median":-5.382384,"eighty":-2.006297,"marketCap":504603752},{"date":"2024-09-20","current":-5.308617,"twenty":-9.22331,"median":-5.392613,"eighty":-2.04582,"marketCap":538007099},{"date":"2024-09-27","current":-4.775651,"twenty":-9.22331,"median":-5.402605,"eighty":-2.071356,"marketCap":483993176},{"date":"2024-10-04","current":-4.312813,"twenty":-9.22331,"median":-5.402605,"eighty":-2.098777,"marketCap":437086348},{"date":"2024-10-11","current":-4.221648,"twenty":-9.22331,"median":-5.402605,"eighty":-2.13584,"marketCap":427847125},{"date":"2024-10-18","current":-4.761626,"twenty":-9.22331,"median":-5.402605,"eighty":-2.165516,"marketCap":482571757},{"date":"2024-10-25","current":-4.744094,"twenty":-9.22331,"median":-5.402605,"eighty":-2.226131,"marketCap":480794983},{"date":"2024-10-31","current":-4.740588,"twenty":-9.22331,"median":-5.402605,"eighty":-2.244588,"marketCap":480439628},{"date":"2024-11-08","current":-5.231477,"twenty":-9.225312,"median":-5.405129,"eighty":-2.271833,"marketCap":530189294},{"date":"2024-11-15","current":-5.809106,"twenty":-9.225312,"median":-5.445898,"eighty":-2.292553,"marketCap":601358704},{"date":"2024-11-22","current":-5.774753,"twenty":-9.225312,"median":-5.463564,"eighty":-2.309931,"marketCap":597802473},{"date":"2024-11-29","current":-5.888119,"twenty":-9.225312,"median":-5.498958,"eighty":-2.31901,"marketCap":609538036},{"date":"2024-12-06","current":-6.279744,"twenty":-9.225312,"median":-5.534802,"eighty":-2.33289,"marketCap":650079072},{"date":"2024-12-13","current":-5.90186,"twenty":-9.225312,"median":-5.583452,"eighty":-2.353729,"marketCap":610960528},{"date":"2024-12-20","current":-5.620165,"twenty":-9.225312,"median":-5.617263,"eighty":-2.367082,"marketCap":581799432},{"date":"2024-12-27","current":-5.496493,"twenty":-9.225312,"median":-5.622268,"eighty":-2.3962,"marketCap":568997000},{"date":"2025-01-03","current":-4.885009,"twenty":-9.225312,"median":-5.622268,"eighty":-2.406198,"marketCap":505696083},{"date":"2025-01-10","current":-5.11861,"twenty":-9.227313,"median":-5.624371,"eighty":-2.432957,"marketCap":529878456},{"date":"2025-01-17","current":-4.610184,"twenty":-9.227313,"median":-5.624371,"eighty":-2.450298,"marketCap":477246233},{"date":"2025-01-24","current":-4.850655,"twenty":-9.227313,"median":-5.624371,"eighty":-2.462386,"marketCap":502139852},{"date":"2025-01-31","current":-4.809432,"twenty":-9.227313,"median":-5.624371,"eighty":-2.492163,"marketCap":497872375},{"date":"2025-02-07","current":-4.747596,"twenty":-9.227313,"median":-5.624371,"eighty":-2.545445,"marketCap":491471158},{"date":"2025-02-14","current":-4.280394,"twenty":-9.227313,"median":-5.624371,"eighty":-2.577061,"marketCap":443106413},{"date":"2025-02-21","current":-4.555219,"twenty":-9.227313,"median":-5.624371,"eighty":-2.609749,"marketCap":471556263},{"date":"2025-02-28","current":-4.886485,"twenty":-9.227313,"median":-5.624371,"eighty":-2.682852,"marketCap":464504340},{"date":"2025-03-07","current":-4.528833,"twenty":-9.229315,"median":-5.62647,"eighty":-2.751011,"marketCap":430506348},{"date":"2025-03-14","current":-4.212868,"twenty":-9.229315,"median":-5.62647,"eighty":-2.800801,"marketCap":400471021},{"date":"2025-03-21","current":-4.682765,"twenty":-9.229315,"median":-5.62647,"eighty":-2.864367,"marketCap":445138943},{"date":"2025-03-28","current":-4.51263,"twenty":-9.229315,"median":-5.62647,"eighty":-2.887636,"marketCap":428966075},{"date":"2025-04-04","current":-3.613344,"twenty":-9.229315,"median":-5.62647,"eighty":-2.950267,"marketCap":343480914},{"date":"2025-04-11","current":-3.370294,"twenty":-9.227313,"median":-5.624371,"eighty":-3.036633,"marketCap":320376817},{"date":"2025-04-17","current":-3.564734,"twenty":-9.227313,"median":-5.624371,"eighty":-3.077604,"marketCap":338860095},{"date":"2025-04-25","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.116395,"marketCap":398160611},{"date":"2025-05-02","current":-4.188563,"twenty":-9.229315,"median":-5.62647,"eighty":-3.213748,"marketCap":398160611},{"date":"2025-05-09","current":-4.698968,"twenty":-9.229315,"median":-5.62647,"eighty":-3.305959,"marketCap":446679216},{"date":"2025-05-16","current":-5.195017,"twenty":-9.229315,"median":-5.62647,"eighty":-3.335282,"marketCap":468798303},{"date":"2025-05-23","current":-5.186029,"twenty":-9.229315,"median":-5.62647,"eighty":-3.341904,"marketCap":467987234},{"date":"2025-05-30","current":-5.042222,"twenty":-9.229315,"median":-5.61173,"eighty":-3.341904,"marketCap":455010118},{"date":"2025-06-06","current":-4.907403,"twenty":-9.1665,"median":-5.562525,"eighty":-3.341904,"marketCap":442844072},{"date":"2025-06-13","current":-6.426361,"twenty":-9.1665,"median":-5.534802,"eighty":-3.341904,"marketCap":579914856},{"date":"2025-06-20","current":-6.093808,"twenty":-9.168041,"median":-5.530847,"eighty":-3.339066,"marketCap":549905276},{"date":"2025-06-27","current":-3.244638,"twenty":-9.078131,"median":-5.526011,"eighty":-3.334336,"marketCap":292796172},{"date":"2025-07-03","current":-4.278249,"twenty":-8.981846,"median":-5.496493,"eighty":-3.33323,"marketCap":386069191},{"date":"2025-07-11","current":-3.954684,"twenty":-8.930849,"median":-5.462896,"eighty":-3.33323,"marketCap":356870681},{"date":"2025-07-18","current":-3.640107,"twenty":-8.858572,"median":-5.407653,"eighty":-3.33323,"marketCap":328483240},{"date":"2025-07-25","current":-3.694034,"twenty":-8.833277,"median":-5.382384,"eighty":-3.33323,"marketCap":333349659},{"date":"2025-08-01","current":-3.316542,"twenty":-8.74252,"median":-5.347811,"eighty":-3.316542,"marketCap":299284730},{"date":"2025-08-08","current":-3.163747,"twenty":-8.648531,"median":-5.308617,"eighty":-3.29177,"marketCap":285496544},{"date":"2025-08-15","current":-3.701442,"twenty":-8.585874,"median":-5.28636,"eighty":-3.28059,"marketCap":324786691},{"date":"2025-08-22","current":-3.550568,"twenty":-8.510418,"median":-5.26529,"eighty":-3.28059,"marketCap":311548103},{"date":"2025-08-29","current":-3.731616,"twenty":-8.456341,"median":-5.254536,"eighty":-3.28059,"marketCap":327434408},{"date":"2025-09-05","current":-3.580742,"twenty":-8.309672,"median":-5.247127,"eighty":-3.279988,"marketCap":314195820},{"date":"2025-09-12","current":-3.7115,"twenty":-8.255139,"median":-5.235483,"eighty":-3.28059,"marketCap":325669263},{"date":"2025-09-19","current":-3.892549,"twenty":-8.21689,"median":-5.210439,"eighty":-3.28059,"marketCap":341555569},{"date":"2025-09-26","current":-3.94284,"twenty":-8.111531,"median":-5.187316,"eighty":-3.28059,"marketCap":345968431},{"date":"2025-10-03","current":-3.952898,"twenty":-8.025162,"median":-5.164674,"eighty":-3.28059,"marketCap":346851004},{"date":"2025-10-10","current":-4.023306,"twenty":-7.942782,"median":-5.143766,"eighty":-3.28059,"marketCap":353029012},{"date":"2025-10-17","current":-3.912665,"twenty":-7.862815,"median":-5.126287,"eighty":-3.28059,"marketCap":343320714},{"date":"2025-10-24","current":-3.983073,"twenty":-7.799198,"median":-5.099688,"eighty":-3.28059,"marketCap":349498721},{"date":"2025-10-31","current":-4.093714,"twenty":-7.710945,"median":-5.053881,"eighty":-3.28059,"marketCap":359207019},{"date":"2025-11-07","current":-4.143879,"twenty":-7.648555,"median":-5.044407,"eighty":-3.28059,"marketCap":347733576},{"date":"2025-11-14","current":-5.044056,"twenty":-7.566386,"median":-5.044056,"eighty":-3.28059,"marketCap":423271942},{"date":"2025-11-21","current":-5.55813,"twenty":-7.566386,"median":-5.044056,"eighty":-3.28059,"marketCap":466410460},{"date":"2025-11-28","current":-6.540439,"twenty":-7.511606,"median":-5.044056,"eighty":-3.28059,"marketCap":548840945},{"date":"2025-12-05","current":-6.602611,"twenty":-7.446462,"median":-5.044056,"eighty":-3.28059,"marketCap":554058064},{"date":"2025-12-12","current":-6.639913,"twenty":-7.388353,"median":-5.044056,"eighty":-3.28059,"marketCap":557188335},{"date":"2025-12-19","current":-6.279319,"twenty":-7.280593,"median":-5.044056,"eighty":-3.28059,"marketCap":526929044},{"date":"2025-12-26","current":-4.948849,"twenty":-7.205023,"median":-5.042222,"eighty":-3.28059,"marketCap":415282692},{"date":"2026-01-02","current":-4.48878,"twenty":-7.158501,"median":-5.023558,"eighty":-3.28059,"marketCap":376676009},{"date":"2026-01-09","current":-5.307185,"twenty":-7.114457,"median":-5.022421,"eighty":-3.28059,"marketCap":445352424},{"date":"2026-01-16","current":-5.51531,"twenty":-7.007306,"median":-5.022421,"eighty":-3.28059,"marketCap":462817225},{"date":"2026-01-23","current":-6.9982,"twenty":-6.984046,"median":-5.022421,"eighty":-3.28059,"marketCap":587253932},{"date":"2026-01-30","current":-6.633981,"twenty":-6.949155,"median":-5.022421,"eighty":-3.28059,"marketCap":556690530},{"date":"2026-02-06","current":-7.342419,"twenty":-6.949155,"median":-5.022421,"eighty":-3.28059,"marketCap":616139063},{"date":"2026-02-13","current":-6.820092,"twenty":-6.936424,"median":-5.022421,"eighty":-3.28059,"marketCap":572308032},{"date":"2026-02-20","current":-6.700703,"twenty":-6.909634,"median":-5.022421,"eighty":-3.28059,"marketCap":562289511},{"date":"2026-02-27","current":-6.655932,"twenty":-6.86795,"median":-5.022421,"eighty":-3.28059,"marketCap":558532565},{"date":"2026-03-06","current":-4.982649,"twenty":-6.839679,"median":-5.015258,"eighty":-3.28059,"marketCap":438936467},{"date":"2026-03-13","current":-5.315427,"twenty":-6.799476,"median":-5.015258,"eighty":-3.28059,"marketCap":468251938},{"date":"2026-03-20","current":-5.051022,"twenty":-6.771856,"median":-5.015258,"eighty":-3.28059,"marketCap":444959705},{"date":"2026-03-27","current":-4.726103,"twenty":-6.758392,"median":-4.993045,"eighty":-3.28059,"marketCap":416336566},{"date":"2026-04-02","current":-4.60795,"twenty":-6.742082,"median":-4.985041,"eighty":-3.28059,"marketCap":405928152},{"date":"2026-04-10","current":-4.991946,"twenty":-6.724631,"median":-4.97902,"eighty":-3.28059,"marketCap":439755498},{"date":"2026-04-17","current":-5.183944,"twenty":-6.698372,"median":-4.968056,"eighty":-3.28059,"marketCap":456669171},{"date":"2026-04-24","current":-4.268262,"twenty":-6.667857,"median":-4.968056,"eighty":-3.28059,"marketCap":376003961},{"date":"2026-05-01","current":-5.731651,"twenty":-6.635138,"median":-4.968056,"eighty":-3.28059,"marketCap":504918330},{"date":"2026-05-08","current":-6.701623,"twenty":-6.633981,"median":-4.968056,"eighty":-3.28059,"marketCap":590366048},{"date":"2026-05-15","current":-6.23472,"twenty":-6.623275,"median":-4.968056,"eighty":-3.28059,"marketCap":567864529},{"date":"2026-05-22","current":-6.256072,"twenty":-6.576982,"median":-4.968056,"eighty":-3.28059,"marketCap":569809271},{"date":"2026-05-29","current":-6.554997,"twenty":-6.563229,"median":-4.964679,"eighty":-3.279988,"marketCap":597035652},{"date":"2026-06-05","current":-6.23472,"twenty":-6.540827,"median":-4.968056,"eighty":-3.28059,"marketCap":567864529},{"date":"2026-06-12","current":-5.530111,"twenty":-6.520195,"median":-4.968056,"eighty":-3.28059,"marketCap":503688058},{"date":"2026-06-18","current":-5.63687,"twenty":-6.512293,"median":-4.968056,"eighty":-3.28059,"marketCap":513411766},{"date":"2026-06-26","current":-6.127961,"twenty":-6.456353,"median":-4.964679,"eighty":-3.279988,"marketCap":558140821},{"date":"2026-07-02","current":-6.725811,"twenty":-6.456353,"median":-4.964679,"eighty":-3.279988,"marketCap":612593585},{"date":"2026-07-10","current":-6.661756,"twenty":-6.485149,"median":-4.964679,"eighty":-3.279988,"marketCap":606759360},{"date":"2026-07-17","current":-6.085257,"twenty":-6.489568,"median":-4.964679,"eighty":-3.279988,"marketCap":554251338},{"date":"2026-07-24","current":-6.063906,"twenty":-6.489568,"median":-4.964679,"eighty":-3.279988,"marketCap":552306597},{"date":"2026-07-31","current":-6.362831,"twenty":-6.489911,"median":-4.961303,"eighty":-3.279387,"marketCap":579532978},{"date":"2026-08-07","current":-6.426886,"twenty":-6.486168,"median":-4.961303,"eighty":-3.279387,"marketCap":585367203},{"date":"2026-08-14","current":-6.105176,"twenty":-6.475406,"median":-4.961303,"eighty":-3.279387,"marketCap":560210978},{"date":"2026-08-21","current":-6.253566,"twenty":-6.456483,"median":-4.961303,"eighty":-3.279387,"marketCap":573827217},{"date":"2026-08-28","current":-6.868323,"twenty":-6.456483,"median":-4.961303,"eighty":-3.279387,"marketCap":630237351}],"updateTime":1788198087870},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655288438","title":"U.S. Stocks on the MOVE-Visa, CMS Energy, Ecolab","url":"https://stock-news.laohu8.com/highlight/detail?id=2655288438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655288438?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:08","pubTimestamp":1785262087,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Visa, CMS Energy, EcolabJuly 28 (Reuters)-The benchmark S&P 500 edged higher in a choppy session on Tuesday, as gains in other sectors offset a decline in chip stocks ahea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL6N43U0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SUPL","CVLT","DISK","ECL","BA","IOND","CNC","CINF","JNJ","CLVT","IQV","CMS","CRM","DINO","SHW","BE","JRE","ALT","NVTS","CORZ","WELL","CNP","ENLV","CRCL","NOW","REPL","FSTA","CARR","GLW","INCY","WDAY","XYL","IBM","UHS","UPS","BOED","KO","STX","V","RCL","CDNS","AMKR","AMT","CISS","QQQG","COHR","INTU","SNDK","IMPP","BZFD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655404889","title":"Barclays says trial data highlights meaningful opportunity for Altimmune in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2655404889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655404889?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:50","pubTimestamp":1785257428,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle notes Altimmune (ALT) reported topline data from the Phase 2 RECLAIM trial of pemvidutide for alcohol use disorder, d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-says-trial-data-highlights-meaningful-opportunity-for-altimmune-in-aud-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-says-trial-data-highlights-meaningful-opportunity-for-altimmune-in-aud-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","CROC","BK4139","LU1878469433.USD","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888595","title":"H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888595","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654888595?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:20","pubTimestamp":1785252026,"startTime":"0","endTime":"0","summary":"H.C. Wainwright reiterates a Buy rating on Altimmune (ALT) with a $20 price target saying the company announced positive topline results from the P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-sees-clear-phase-2-win-for-altimmune-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/h-c-wainwright-sees-clear-phase-2-win-for-altimmune-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALT","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888427","title":"Leerink remains bullish on Altimmune following ‘positive’ AUD trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654888427?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:21","pubTimestamp":1785248461,"startTime":"0","endTime":"0","summary":"Leerink notes Altimmune (ALT) announced “positive topline results” from its Phase 2 RECLAIM trial of lead asset pemvidutide in patients with alcoho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-remains-bullish-on-altimmune-following-positive-aud-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-remains-bullish-on-altimmune-following-positive-aud-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CROC","ALT","BK4139","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654700068","title":"Unusually active option classes on open July 28th","url":"https://stock-news.laohu8.com/highlight/detail?id=2654700068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654700068?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:40","pubTimestamp":1785246031,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Hubbell (HUBB), Kimberly Clark (KMB), Altimmune (ALT), Replimune Group (REPL), Pan American Si...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-july-28th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-july-28th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001440.SGD","LU0390134368.USD","REPL","LU1585245621.USD","IE00BFXG1179.USD","BK4504","BK4567","RSPS","LU1978683503.SGD","BK4585","BK4139","HUBB","LU0347712357.USD","LU1430594728.SGD","LU1878469433.USD","KMB","LU0124384867.USD","BK4588","IE00BN0W2W23.USD","IE00BGHQF417.EUR","ALT","LU1721428933.USD","BK4096","IE00B2PGVK34.USD","LU1153585028.USD","IE00BN0W2V16.EUR","IE00B3CCJ633.GBP","BK4599","IE0034235188.USD","LU1571399168.USD","LU2413666699.HKD","LU2413666426.HKD","LU0724618433.USD","IE00BN0W2T93.GBP","LU0011850046.USD","BK4018","LU2463526074.USD","LU2298322129.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654026004","title":"Altimmune's Investigational Alcohol Use Disorder Drug Meets Primary Endpoint in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2654026004","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654026004?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:32","pubTimestamp":1785241974,"startTime":"0","endTime":"0","summary":"Altimmune's  investigational drug Pemvidutide met its primary and several secondary endpoints in a phase 2 study for treatment of alcohol use disorder, the company said Tuesday.A 2.4 mg dose yielded a \"statistically significant and clinically meaningful\" reduction in heavy drinking days versus placebo, the primary endpoint of the approximately 100-patient study, the company said.The company also met secondary endpoints including a two-level reduction in World Health Organization Risk Drinking Levels and achieving zero heavy-drinking days versus placebo, the company said.The drug also showed generally favorable tolerability, the company said.Based on the data, Altimmune plans to request an End-of-Phase 2 meeting with the U.S. Food and Drug Administration to discuss pemvidutide's path forward in alcohol use disorder, the company said.Shares of the company were up more than 11% in recent premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","LU1878469433.USD","BK4139","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004929","title":"Altimmune Shares Jump Premarket After Positive Results in Phase 2 Trial of Pemvidutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004929","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004929?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:14","pubTimestamp":1785240840,"startTime":"0","endTime":"0","summary":"Altimmune's shares are set to rally at the opening bell after the biopharmaceutical company reported positive results in a study of its investigational treatment for patients with moderate-to-severe alcohol-use disorder.In premarket trading, the shares were 9.5% higher at $3.24. That helps unwind some of the 18% drop so far this year for the stock through Monday's close.Altimmune said it plans to request an end-of-Phase 2 meeting with the U.S. Food and Drug Administration based on the top-line results from its trial evaluating pemvidutide, a balanced glucagon/GLP-1 dual receptor agonist.The trial met its primary endpoint with a highly statistically significant reduction in heavy-drinking days versus placebo, with consistent positive results across important secondary endpoints, including the World Health Organization risk drinking levels, zero heavy-drinking days and phosphatidyl ethanol levels.A generally favorable tolerability profile was observed in the trial, the company said.Chief","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654092120","title":"Altimmune Jumps as Experimental Obesity Drug Shows Benefit in Alcohol Use Disorder Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2654092120","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654092120?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:33","pubTimestamp":1785238382,"startTime":"0","endTime":"0","summary":"BUZZ-Altimmune jumps as experimental obesity drug shows benefit in alcohol use disorder study** Shares of drug developer AltimmuneALT.Orise ~19% to $3.51 premarket** Co says its experimental weight-loss drug, pemvidutide,met the main goalofa mid-stage study in patients with moderate to severe alcohol use disorder** The drug helped significantly reduce heavy drinking days compared with placebo, the main goal of the study - ALT** Nearly two-thirds of patients treated with pemvidutide also achieved a two-level reduction in their WHO-RDL, a secondary goal of the study - ALT** WHO-RDL categorizes average daily or weekly alcohol consumption into no risk, low risk, medium risk, high risk, and very high risk** Pemvidutide belongs to the same class of drugs as Novo Nordisk'sNOVOb.COWegovy , and Eli Lilly'sLLY.NZepbound, known as GLP-1 agonists** It is also being tested to treat metabolic dysfunction-associated steatohepatitis, or MASH, a serious type of fatty liver disease** Up to last close, A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL4N43U17X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006062","title":"Altimmune Shares up 17% Premarket as Co's Drug Meets Main Goal of Mid-Stage Study for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006062?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:11","pubTimestamp":1785237119,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43U0L7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","LU1878469433.USD","BK4139","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654700625","title":"Altimmune's Drug Meets Main Goal of Mid-stage Study for Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2654700625","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654700625?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:06","pubTimestamp":1785236797,"startTime":"0","endTime":"0","summary":"Altimmune's drug meets main goal of mid-stage study for alcohol use disorderJuly 28 (Reuters)-AltimmuneALT.Osaid on Tuesday its experimental drug met the main goal of a mid-stage trial for alcohol use disorder.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL4N43U13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALT","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654139006","title":"Altimmune - to Request End-of-Phase 2 Meeting with FDA for Pemvidutide in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2654139006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654139006?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA39FSSN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALT","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006662","title":"Altimmune - Pemvidutide Meets FDA-Recognized Registrational Endpoints in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006662?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA39FSSN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1878469433.USD","ALT","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006542","title":"Altimmune Announces Positive Topline Results from Reclaim Phase 2 Trial of Pemvidutide in Alcohol Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006542?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA39FSSN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006138","title":"Altimmune - Pemvidutide 2.4 Mg Achieves Significant Reduction in Heavy Drinking Days in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006138?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA39FSSN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALT","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006130","title":"Altimmune - Pemvidutide Demonstrates Generally Favorable Tolerability Profile in Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006130?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nTUA39FSSN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484733","title":"Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484733","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484733?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:53","pubTimestamp":1784062380,"startTime":"0","endTime":"0","summary":"REVTORPYK (gedatolisib)   REVTORPYK (gedatolisib) vial and box  REVTORPYKis the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/14/3327323/0/en/Celcuity-Announces-FDA-Approval-of-REVTORPYK-gedatolisib-for-the-Treatment-of-HR-HER2-PIK3CA-Wild-Type-Locally-Advanced-or-Metastatic-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","BK4599","HR","IE00B7SZL793.SGD","BK4157","IE00B66KJ199.SGD","BK4203","IE00B19Z4B17.USD","LU0757428866.USD","ALT","BK4588","LABU","BK4225","GDOC","AEIS","MEDX","BK4585","SRET","HYLG","BK4139","LU1878469433.USD","IDNA","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645816531","title":"Unusually active option classes on open June 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=2645816531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645816531?lang=en_us&edition=fundamental","pubTime":"2026-06-24 21:40","pubTimestamp":1782308421,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: iShares Germany (EWG), Sunrun (RUN), Altimmune (ALT), Newell Brands (NWL), BP (BP), ProShares ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-june-24th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-june-24th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RUN","BK4096","LU2294711713.HKD","LU1829250122.USD","LU1162221912.USD","BPH","ALT","LU0006061336.USD","LU2357125470.USD","BK4599","LU0823414551.USD","LU2506951792.HKD","LU0162691827.USD","LU0300736062.USD","BP","BK4585","BK4201","LU1878469433.USD","LU0823414478.USD","BK4139","NWL","LU0300736492.USD","LU2249611893.SGD","BK4588","BK4180","BK4551","EWG","LU0072461881.USD","BK4596","LU0320765646.SGD","BK4519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645207309","title":"Altimmune Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2645207309","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645207309?lang=en_us&edition=fundamental","pubTime":"2026-06-22 22:49","pubTimestamp":1782139740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 10:49 ET (14:49 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU1878469433.USD","ALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645402988","title":"Leerink Partners Initiates Altimmune at Outperform With $10 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2645402988","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645402988?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:51","pubTimestamp":1782125474,"startTime":"0","endTime":"0","summary":"Altimmune (ALT) has an average rating of overweight and mean price target of $16.06, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU1878469433.USD","ALT","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645026939","title":"Altimmune Inc : Leerink Partners Initiates Coverage With Outperform Rating; Price Target $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2645026939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645026939?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:34","pubTimestamp":1782124489,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42U023:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALT","BK4139","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":128,"code":"91000000","status":"200"}]}}